Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin

The Microscope is publishing monographs from McCrone Research Institute’s A Modern Compendium of Microcrystal Tests for Illicit Drugs and Diverted Pharmaceuticals (4th revision: September 13, 2021), which contains 19 different drugs and their microcrystal test reagents. This issue includes the final installment of monographs, with the following drugs/reagents: • phencyclidine (PCP)/potassium permanganate• phencyclidine (PCP)/ammonium thiocyanate• pseudoephedrine/dilituric acid• pseudoephedrine/gold chloride• psilocin/trinitrobenzoic acid The previous set of monographs were published in issue 66:4 (2018): oxycodone with platinum bromide, oxycodone with potassium triiodide (Clarke’s I-KI, No. 1), and oxycodone with sodium carbonate.

Open source BibTeX RIS

Bibliographic context

Journal
The Microscope
Date
2018-12-31
Source
OpenAlex
DOI
10.59082/tnwk8166
PubMed
Unavailable

Authors

Kelly M. BrinskoDean GolemisMeggan B. KingGary J. LaughlinSebastian B. Sparenga
Watch author

Topics and keywords

psilocybinpsilocin PharmacologyReceptor PharmacologyMetabolomics Other PseudoephedrinePhencyclidinePsilocybinHallucinogenDesigner drugIdentification (biology)Illicit drugChemistryPharmacologyEphedrineMedicineDrugBotanyBiochemistryReceptorBiologyNMDA receptorChromatography in Natural ProductsMetabolomics and Mass Spectrometry StudiesMolecular spectroscopy and chirality

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Microcrystal Tests for the Identification of Illicit Drugs: Phencyclidine, Pseudoephedrine, and Psilocin2018-12-31

Related papers

Studies on enzymatic hydrolysis of psilocin- O -glucuronide for screening of psilocin in human urine by liquid chromatography-triple quadrupole tandem mass spectrometryJournal of Analytical Toxicology · 2026-05-26Blocking 5-HT2B receptors abolishes psilocybin’s efficacy in the rat forced swim testJournal of Psychopharmacology · 2026-06-22Pharmacokinetic and pharmacodynamic rational for expanding the therapeutic landscape of psilocybin beyond depressionPharmacological Research · 2026-06-10Current status and future prospects of research on psilocybin's regulation of neurotransmitters and their receptors related to the pathogenesis of tinnitusHearing Research · 2026-06-03Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31A spatiotemporal gating hypothesis for psilocybin plasticity: reconciling the 5-HT₂A-TrkB mechanistic paradoxCell Discovery · 2026-05-28Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic PotentialDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21